Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 17914039)


Medication development for agitation and aggression in Alzheimer disease: review and discussion of recent randomized clinical trial design.

Soto M, Andrieu S, Nourhashemi F, Ousset PJ, Ballard C, Robert P, Vellas B, Lyketsos CG, Rosenberg PB.

Int Psychogeriatr. 2014 Sep 16:1-17. [Epub ahead of print]


Depressive Symptoms in Clinical and Incipient Alzheimer's Disease.

Hsiao JJ, Teng E.

Neurodegener Dis Manag. 2013;3(2):147-155.


Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

Herrmann N, Lanctôt KL, Hogan DB.

Alzheimers Res Ther. 2013 Jul 8;5(Suppl 1):S5. doi: 10.1186/alzrt201. Epub 2013 Jul 8.


Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial.

Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

JAMA. 2014 Feb 19;311(7):682-91. doi: 10.1001/jama.2014.93.


Treatment of Alzheimer's Disease: Current Management and Experimental Therapeutics.

Honig LS, Boyd CD.

Curr Transl Geriatr Exp Gerontol Rep. 2013 Sep;2(3):174-181.



Butler R, Radhakrishnan R.

BMJ Clin Evid. 2012 Sep 10;2012. pii: 1001.


The threat of behavioral changes in dementia.

Burke AD, Yaari R, Tariot PN, Hall GR, Dougherty J, Brand H, Fleisher AS.

Prim Care Companion CNS Disord. 2013;15(1). pii: PCC.13alz01507. doi: 10.4088/PCC.13alz01507. Epub 2013 Feb 28. No abstract available.


NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer's Disease.

Huang YJ, Lin CH, Lane HY, Tsai GE.

Curr Neuropharmacol. 2012 Sep;10(3):272-85. doi: 10.2174/157015912803217288.


Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer's disease receiving donepezil.

Kano O, Ito H, Takazawa T, Kawase Y, Murata K, Iwamoto K, Nagaoka T, Hirayama T, Miura K, Nagata R, Kiyozuka T, Aoyagi J, Sato R, Eguchi T, Ikeda K, Iwasaki Y.

Neuropsychiatr Dis Treat. 2013;9:259-65. doi: 10.2147/NDT.S40682. Epub 2013 Feb 15.


Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review.

Seitz DP, Gill SS, Herrmann N, Brisbin S, Rapoport MJ, Rines J, Wilson K, Le Clair K, Conn DK.

Int Psychogeriatr. 2013 Feb;25(2):185-203. doi: 10.1017/S1041610212001627. Epub 2012 Oct 19. Review.


Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.

Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G.

PLoS One. 2012;7(5):e35185. doi: 10.1371/journal.pone.0035185. Epub 2012 May 2.


Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: results of a survey.

Vale CL, Thompson LC, Murphy C, Forcat S, Hanley B.

Trials. 2012 Jan 13;13:9. doi: 10.1186/1745-6215-13-9.


Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

Basselin M, Ramadan E, Rapoport SI.

Brain Res Bull. 2012 Feb 10;87(2-3):154-71. doi: 10.1016/j.brainresbull.2011.12.001. Epub 2011 Dec 9. Review.



Warner JP, Butler R, Gupta S.

BMJ Clin Evid. 2010 Apr 8;2010. pii: 1001.


Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials.

Kim DH, Brown RT, Ding EL, Kiel DP, Berry SD.

J Am Geriatr Soc. 2011 Jun;59(6):1019-31. doi: 10.1111/j.1532-5415.2011.03450.x. Epub 2011 Jun 7.


The geriatric population and psychiatric medication.

Varma S, Sareen H, Trivedi JK.

Mens Sana Monogr. 2010 Jan;8(1):30-51. doi: 10.4103/0973-1229.58818.


Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy.

Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, Lenze EJ, Holm M, Rogers JC, Mazumdar S, Houck PR, Begley A, Anderson S, Karp JF, Miller MD, Whyte EM, Stack J, Gildengers A, Szanto K, Bensasi S, Kaufer DI, Kamboh MI, DeKosky ST.

Arch Gen Psychiatry. 2011 Jan;68(1):51-60. doi: 10.1001/archgenpsychiatry.2010.184.


Drugs for Alzheimer's disease: are they effective?

Casey DA, Antimisiaris D, O'Brien J.

P T. 2010 Apr;35(4):208-11. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk